Rivaroxaban in Thrombotic Antiphospholipid Syndrome
Clinical trial NCT02157272 · TERMINATED
Trial details
- NCT number
- NCT02157272
- Sponsor
- University of Padova
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-01-25
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.